HYQVIA (Baxalta US Inc.)
Welcome to the PulseAid listing for the HYQVIA drug offered from Baxalta US Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
| NON-PROPRIETARY NAME: | HUMAN IMMUNEGLOBULIN G and HYALURONIDASE (HUMAN RECOMBINANT) |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-09-12 |
| END MARKETING DATE: | 0000-00-00 |
HYQVIA PLASMA DERIVATIVE Details:
| Item Description | HYQVIA from Baxalta US Inc. |
| LABELER NAME: | Baxalta US Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-09-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0944-2510_cd8adb46-3f21-4cd8-991d-43d1a9230f0a |
| PRODUCT NDC: | 0944-2510 |
| APPLICATION NUMBER: | BLA125402 |